FIELD: medicine.
SUBSTANCE: invention concerns medicine and pharmacology and represents the medical ointment including lidocaine hydrochloride, vaseline and the purified water, having as the operating substance additionally contains dexamethasone, thrombolysin and sea-buckthorn oil. As the base for the ointment lanolin waterless and cleared medical vaseline are used, thus, components in ointment are in a certain ratio in %.
EFFECT: invention provides the improvement of the efficiency of medical ointment external application as well as decrease in frequency of complications in case of inflammation of mucous membranes with acceleration of their restoration, and as high permeability of fabrics, acceleration of liquid and operating substances movement through interfabric spaces in depth of fabrics and their more long local medical influence.
1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT | 2010 |
|
RU2429818C1 |
| OINTMENT FOR TREATING BITTEN WOUNDS | 2011 |
|
RU2473329C2 |
| TOPICAL PREPARATION FOR CONTAMINATED WOUND HEALING | 2012 |
|
RU2512824C2 |
| AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
| METHOD OF BITE WOUNDS TREATMENT | 2015 |
|
RU2597767C2 |
| THERAPEUTIC AGENT CONTAINING COMBINATION OF ACTIVE SUBSTANCES CONTAINING PANTOTHENIC ACID OR ITS DERIVATIVES FOR TREATING ALLERGIC SYMPTOMS | 2008 |
|
RU2472499C2 |
| AGENT FOR TREATMENT OF DERMATOLOGICAL DISEASES | 2001 |
|
RU2197247C2 |
| MEDICATION FOR LOCAL TREATMENT OF DISEASES OF PARODENTIUM AND ORAL CAVITY MUCOUS MEMBRANE | 2008 |
|
RU2383337C1 |
| BEESWAX BASED OINTMENT FOR THE TREATMENT OF ANIMAL SKIN DISEASES | 2022 |
|
RU2802235C1 |
| MEANS FOR NASAL APPLICATION | 2016 |
|
RU2629330C1 |
